Brugnera Nunes de Mattos, A., M. Maria Cerneski, S. Reichert, and C. Nava Jaeger. “Use of Adalimumab, a TNF-Alpha Inhibitor, Is Associated With Paradoxical Psoriasis: Two Clinical Case Reports”. Brazilian Journal of Case Reports, vol. 3, no. 2, Jan. 2023, pp. 12-15, doi:10.52600/2763-583X.bjcr.2023.3.2.12-15.